Supernus, Inc. (INDV) stock
INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SUPN
$35.37+0.12 (+0.34%)
Close on Oct 30, 2026Market cap $4.17BP/E 9.9Yield –
Supernus profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Supernus's profit margin for the twelve months ending Sep 30, 2026 was 32.8%. For fiscal 2025 it was 16.9%, against 0.6% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16.9% | +16.4 |
| FY2024 | Dec 31, 2024 | 0.6% | +12.1 |
| FY2023 | Dec 31, 2023 | -11.5% | −6.9 |
| FY2022 | Dec 31, 2022 | -4.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 38.5% | +25.1 |
| Q2 FY2026 | Jun 30, 2026 | 35.6% | +29.6 |
| Q1 FY2026 | Mar 31, 2026 | 28.1% | +10.4 |
| Q4 FY2025 | Dec 31, 2025 | 28.5% | +21.5 |
| Q3 FY2025 | Sep 30, 2025 | 13.4% | +6.2 |
| Q2 FY2025 | Jun 30, 2025 | 6.0% | +38.4 |
| Q1 FY2025 | Mar 31, 2025 | 17.7% | −3.8 |
| Q4 FY2024 | Dec 31, 2024 | 7.0% | – |
| Q3 FY2024 | Sep 30, 2024 | 7.2% | – |
| Q2 FY2024 | Jun 30, 2024 | -32.4% | – |
| Q1 FY2024 | Mar 31, 2024 | 21.5% | – |
See a number that looks wrong?